IL6R and head and neck squamous cell carcinoma: To begin elucidating the mechanisms underlying the anti-CSC effect of therapeutic blockade of IL-6R, we examined the impact of the IL-6 pathway on downstream signaling effectors in three HNSCC cell lines.